Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 27 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 24 25 26 27 presentations: 1 to 25 of 653
Neratinib in HER2 or HER3 mutant solid tumors: SUMMIT, a global, multi-histology, open-label, phase 2 "basket" study
David M Hyman
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2017 on April 2, 2017 12:45 PM-3:00 PM
Discussant
Howard Burris
Sarah Cannon Research Institute, Nashville, TN, United States
from AACR Annual Meeting 2017 on April 2, 2017 12:45 PM-3:00 PM
A Phase IB study of RAF dimer inhibitor BGB-283 in patients with B-RAF or K-RAS/N-RAS mutated solid tumors
Jayesh Desai
Royal Melbourne Hospital, Melbourne, Australia
from AACR Annual Meeting 2017 on April 2, 2017 12:45 PM-3:00 PM
Activity of the ERK1/2 inhibitor ulixertinib (BVD-523) in patients with BRAF and NRAS mutant melanoma
Ryan J Sullivan
Harvard Medical School/MGH, Boston, MA, United States
from AACR Annual Meeting 2017 on April 2, 2017 12:45 PM-3:00 PM
Discussant
Alex A. Adjei
Mayo Clinic, Rochester, MN, United States
from AACR Annual Meeting 2017 on April 2, 2017 12:45 PM-3:00 PM
European pediatric precision medicine program in recurrent tumors: first results from MAPPYACTS molecular profiling trial towards AcSe-ESMART proof-of-concept study
Birgit Geoerger
Inst. Gustave Roussy, Villejuif, France
from AACR Annual Meeting 2017 on April 2, 2017 12:45 PM-3:00 PM
Discussant
Yael P Mosse
Children's Hospital of Philadelphia, Philadelphia, PA, United States
from AACR Annual Meeting 2017 on April 2, 2017 12:45 PM-3:00 PM
Final results of the HERACLES trial in HER2-amplified colorectal cancer
Silvia Marsoni
Grande Ospedale Metropolitano Niguarda, Milano, Italy
from AACR Annual Meeting 2017 on April 2, 2017 12:45 PM-3:00 PM
Discussant
Rodrigo Dienstmann
Vall dĀ“Hebron Inst. of Oncology, Barcelona, Spain
from AACR Annual Meeting 2017 on April 2, 2017 12:45 PM-3:00 PM
Somatic HLA mutations and neoantigen identification for immunotherapy analyses
Sachet A Shukla
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Dynamics of genomic and neoantigen landscape during immune checkpoint blockade
Valsamo Anagnostou
Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Integrative clinical and genomic analysis of solid tumors treated with immune checkpoint blockade
Jeffrey E Hammerbacher
Icahn School Of Medicine At Mount Sinai, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Infiltrating immune cell signatures and genomic determinants of immune recognition in diverse tumors
Ash A. Alizadeh
Stanford Univ., Stanford, CA, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Ultrasensitive mutation detection to enable cancer detection and treatment
Luis A. Diaz
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-3:00 PM
Enabling the early detection of pancreatic cancer
Alison P. Klein
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-3:00 PM
Incorporating molecular pathology tools into epidemiological studies of colorectal cancer
Ulrike Peters
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-3:00 PM
Invited Speaker
Daniel S. Chen
Genentech, Inc., South San Francisco, CA, United States
from AACR Annual Meeting 2017 on April 2, 2017 7:00 AM-8:00 AM
Rare and common risk alleles: Cancer prevention and care for individuals and populations
Peter Kraft
Harvard T.H. Chan School of Public Health, Boston, MA, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
The evolving landscape of cancer susceptibility associated with high-penetrance gene mutations
Katherine L. Nathanson
Univ. of Pennsylvania School of Medicine, Philadelphia, PA, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Three components of inherited cancer risk and their implications in personalized cancer screening
Jianfeng Xu
Northshore University Health Systems, Evanston, IL, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Chair
Robert J. Gillies
Moffitt Cancer Center & Research Institute, Tampa, FL, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Tumor immune-pathology from the molecular scale on up
Garry P. Nolan
Stanford Univ. School of Medicine, Stanford, CA, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
To image and imagine: Molecular imaging and theranostics of cancer
Zaver M. Bhujwalla
Johns Hopkins Univ. School of Medicine, Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Imaging tumor habitats: Life at the edge
Robert J. Gillies
Moffitt Cancer Center & Research Institute, Tampa, FL, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Periodontal disease, microbiota dissemination, and cancer
Dominique S. Michaud
Tufts University, Boston, MA, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
<< first | < prev page: of 27 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 24 25 26 27 presentations: 1 to 25 of 653